Posts

Job Market Outlook 2026 – Asrar Qureshi’s Blog Post #1220

Image
Job Market Outlook 2026 – Asrar Qureshi’s Blog Post #1220 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1220 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Rosemary Ketchum Credit: Liliana Drew Preamble This blog post is based on a DevelopmentAid Digest Expert Opinions’ piece. Link at the end. Job Market in 2026: A Year of Transformation, Turbulence, and Opportunity As economies and technologies evolve, the job market is undergoing profound change. The year 2026 is shaping up to be a pivotal moment, defined not by stagnation or chaos, but by dynamic shifts in how work is organized, which skills matter most, and where opportunities are emerging. Understanding these trends is essential for job seekers, employers, educators, and policymakers alike. According to labor experts and global forecasts, 2026 will look...
Post a Comment
Read more

Stress as Energizer – Asrar Qureshi’s Blog Post #1219

Image
Stress as Energizer – Asrar Qureshi’s Blog Post #1219 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1219 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Nathan Cowley Credit: Vera Arsic Preamble Stress is now among the most felt and expressed feeling. This blog post is based on an article by Scott H. Young, who has given some valuable insights on the subject. Link at the end. Stress and Energy: How to Turn a Burden into a Boost Most of us know stress as a drain on energy, that heavy feeling in the chest, that difficulty concentrating, that exhaustion at the end of a long day. Yet, as Scott H. Young shows in his insightful article on stress and energy, stress is neither inherently “good” nor “bad.” Instead, it’s a biological response that has adaptive value at the right intensity and duration, and damaging eff...
Post a Comment
Read more

Doctors & Pharma Industry – Part 2 of 2 – Asrar Qureshi’s Blog Post 1218

Image
Doctors & Pharma Industry – Part 2 of 2 – Asrar Qureshi’s Blog Post 1218 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1218 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: cottonbro studio Preamble Few relationships in modern healthcare are as debated, or as misunderstood, as that between pharmaceutical companies and doctors. To critics, it is a story of undue influence, conflicts of interest, and distorted prescribing. To defenders, it is a necessary partnership that enables medical innovation, education, and patient access to life-saving therapies. The truth lies in between. Code of Conduct – Pharma Companies Pharmaceutical companies play a critical role in safeguarding public health by discovering, manufacturing, and supplying medicines. In Pakistan, where healthcare resources are constrained and patien...
Post a Comment
Read more

Doctors & Pharma Industry – Part 1 of 2 – Asrar Qureshi’s Blog Post 1217

Image
Doctors & Pharma Industry – Part 1 of 2 – Asrar Qureshi’s Blog Post 1217 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1217 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Thirdman Preamble Few relationships in modern healthcare are as debated—or as misunderstood—as that between pharmaceutical companies and doctors. To critics, it is a story of undue influence, conflicts of interest, and distorted prescribing. To defenders, it is a necessary partnership that enables medical innovation, education, and patient access to life-saving therapies. The truth lies in between. Pharma Companies and Doctors –  A Relationship of Necessity, Value, and Risk The relationship between pharma and physicians is structurally unavoidable in a system where: • Drug development is complex and expensive • Clinical knowledg...
Post a Comment
Read more

Organizational Wellbeing – A New Look – Asrar Qureshi’s Blog #Post 1216

Image
Organizational Wellbeing – A New Look – Asrar Qureshi’s Blog #Post 1216 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1216 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Hillary Fox Preamble This blog post is based on an INSEAD KNOWLEDGE article. Link at the end. Rethinking Organizational Well-Being: From Perks to Performance Foundation In recent years, concepts like “well-being at work” have proliferated in corporate discourse. We’ve seen yoga rooms, meditation breaks, gym memberships and digital wellness tools positioned as competitive perks to recruit and retain talent. But growing evidence shows that such superficial initiatives, often treated as human resource frills, are not delivering meaningful impact and are being cut during cost rationalization cycles. Instead of being viewed as an add-on, well-bei...
Post a Comment
Read more

Pharmaceutical Distribution Systems – A Strategic Opportunity – Asrar Qureshi’s Blog Post #1215

Image
Pharmaceutical Distribution Systems – A Strategic Opportunity – Asrar Qureshi’s Blog Post #1215 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1215 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Antonius Natan Credit: Lidia Volovaci Preamble This blog post is based on insights from a McKinsey article. Link at the end. From Warehouse to Wellness: What Modern Pharmaceutical Distribution Means for Pakistan For decades, pharmaceutical distribution in Pakistan has been viewed largely as a logistics function, warehouses, trucks, stockists, and retailers moving cartons of medicines across cities and districts. Yet, as global healthcare systems evolve toward specialty medicines, biologics, and patient-centric care, this traditional view is becoming dangerously outdated. Insights from McKinsey’s discussion with Bob Ma...
Post a Comment
Read more

Implications of US Withdrawal from World Bodies – Asrar Qureshi’s Blog Post #1214

Image
Implications of US Withdrawal from World Bodies – Asrar Qureshi’s Blog Post #1214 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1214 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Safi Erneste Preamble This blog post is based on an article written by Lydia Gichuki for DevelopmentAid Digest.. Link at the end. When a Superpower Steps Back: How the U.S. Exit from 66 Global Bodies Is Rewriting the World System In early January 2026, the United States government made a move with seismic implications for international cooperation: President Donald J. Trump signed a presidential memorandum directing the withdrawal of the U.S. from 66 international organizations, a sweeping disengagement that spans United Nations bodies and non-UN multilateral institutions. This move marks far more than a policy shift. It heralds a ...
Post a Comment
Read more